Immediate intraocular pressure rise after intravitreal injection of ranibizumab and two doses of triamcinolone acetonide

International Journal of Ophthalmology

Volumn 4, Issue 4, 2011, Pages 402-405

  Arikan, Gul ^a   Saatci, Ali Osman ^a   Oner, Ferit Hakan ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Anti VEGF agents; Glaucoma; Intraocular pressure; Intravitreal injection; Steroids

Indexed keywords

EID: 84897594327     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2011.04.16     Document Type: Article

References (20)

1. Wu H, Chen TC The effects of intravitreal ophthalmic medications on intraocular pressure. Semin Ophthalmol. 2009; 24(2):100-105.
2. Hauser D, Bukelman A, Pokroy R., Katz H, Len A, Thein R., Parness-Yossifon R, Pollack A. Intravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4mg. Retina. 2008; 28(6):825-830.
3. Jonas JB, Degenring RF, Kreissig I, Akkoyun I., Kamppeter BA Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology. 2005; 112(4):593-598.
4. Gillies MC, Simpson JM, Billson F.A., Luo W., Penfold P, Chua W, Mitchell P., Zhu M, Hunyor AB Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol. 2004; 122(3):336-340.
5. Vasconcelos-Santos D.V., Nehemy PG, Schachat A.P., Nehemy MB Secondary ocular hypertension after intravitreal injection of 4mg of triamcinolone acetonide: incidence and risk factors. Retina. 2008; 28(4):573-580.
6. Rhee DJ, Peck RE, Belmont J, Martidis A., Liu M, Chang J, Fontanarosa J., Moster MR Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol. 2006; 90(8):999-1003.
7. Inatani M, Iwao K, Kawaji T., Hirano Y, Ogura Y, Hirooka K., Shiraga F, Nakanishi Y, Yamamoto H., Negi A, Shimonagano Y, Sakamoto T, Shima C, Matsumura M, Tanihara H. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study. Am J Ophthalmol. 2008; 145(4):676-681.
8. Benz MS, Albini TA, Holz E.R., Lakhanpal RR, Westfall A C, Iyer MN, Carvounis PE Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology. 2006; 113(7):1174-1178.
9. Kerimoglu H, Ozturk BT, Bozkurt B, Okka M., Okudan S. Does lens status affect the course of early intraocular pressure and anterior chamber changes after intravitreal injection? Acta Ophthalmol. 2011; 89(2):138-142.
10. Falkenstein IA, Cheng L, Freeman WR Changes of intraocular pressure after intravitreal injection of bevacizumab (Avastin) Retina. 2007; 27(8):1044-1047.
11. Gismondi M, Salati C, Salvetat M.L., Zeppieri M., Brusini P. Short-term effect of intravitreal injection of ranibizumab (Lucentis) on intraocular pressure. J Glaucoma. 2009; 18(9):658-661.
12. Dwinger MC, Pieper-Bodeewes I, Eter N., Holz FG Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection. Klin Monbl Augenheilkd. 2005; 222(8):638-642.
13. Hollands H, Wong J, Bruen R., Campbell RJ, Sharma S, Gale J. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol. 2007; 42(6):807-811.
14. Kotliar K, Maier M, Bauer S., Feucht N, Lohmann C, Lanzl I. Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model. Acta Ophthalmol Scand. 2007; 85(7):777-781.
15. Sharei V, Höhn F, Köhler T, Hattenbach LO, Mirshahi A. Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis) Eur J Ophthalmol. 2010; 20(1):174-179.
16. Rosenfeld PJ, Brown DM, Heier J.S., Boyer DS, Kaiser PK, Chung CY, Kim R.Y., MARINA Study Group Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006; 355(14):1419-1431.
17. Cho YK. Early intraocular pressure and anterior chamber depth changes after phacoemulsification and intraocular lens implantation in nonglaucomatous eyes: comparison of groups stratified by axial length. J Cataract Rafract Surg. 2008; 34(7):1104-1109.
18. Kim JE, Mantravadi AV, Hur EY, Covert DJ Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol. 2008; 146(6):930-934.
19. Bakri SJ, Pulido JS, McCannel C.A., Hodge DO, Diehl N, Hillemeier J. Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye. 2009; 23(1):181-185.
20. Frenkel REP, Mani L, Toler A.R., Frenkel MPC. Intraocular pressure effects of pegaptanib (Macugen) injections in patients with and without glaucoma. Am J Ophthalmol. 2007; 143(6):1034-1035.